Nektar TherapeuticsNKTRNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Percentile
P14
Within normal range
vs 5Y Ago
-1.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-43.89%
20249.22%
2023-2.10%
2022-9.67%
2021-33.36%
202033.41%
2019-90.40%
2018287.81%
201786.00%
2016-28.32%